Fractyl Health, Inc (GUTS): Pangali rega marang bathi tumrap wutah

Fractyl Health, Inc. (GUTS) is deploying unique endoscopic diabetes therapy equipment into clinics, creating a steady stream of orders for consumables. The PEG ratio trend captures a peak, after which the indicator leveled off at 0.00. Fractyl Health, Inc. (GUTS) regenerates the intestinal mucosa via Revita, restoring metabolism without the use of medication. The team is expanding by recruiting leading biologists and clinical trial experts.

$GUTS Pangali rega marang bathi tumrap wutah fractyl.com (21.02.2024 - 12.11.2026)$

Rincian analitis perusahaan Fractyl Health, Inc. (GUTS)

- rega saham lan konsensus proyeksi valuasi:

Bagan owah-owahan rega Fractyl Health Inc.|GUTS - Bagan rega target

- data kapitalisasi bursa:

Biji pasar Fractyl|GUTS - Nilai Perusahaan

- indikator nilai buku ekuitas:

Nilai Aset Bersih saben Saham Fractyl Health|GUTS - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku fractyl.com|GUTS - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

- data bathi lan kelipatan valuasi:

GUTS - Bathi resik perusahaan|Prakiraan bathi perusahaan Fractyl Health, Inc.|GUTS - Rasio rega marang bathi|Prakiraan rega marang bathi Fractyl Health, Inc|GUTS - Pangali PEG|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Fractyl|GUTS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Fractyl Health|GUTS - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan fractyl.com|GUTS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Fractyl Health, Inc.

Analisis fundamental perusahaan:GUTS - Fractyl Health Inc.

$Produk mawa merek fractyl.com$

Fractyl Health, Inc. (GUTS) invests in highly skilled personnel and R&D to combat metabolic diseases. By analyzing the PEG ratio trajectory, an investor can see the relationship between market value and earnings growth rates. The current value of 0.00 reflects the efficiency of capitalizing on the company's innovative potential. A value below one signals that the asset is undervalued relative to its expansion. The market interprets such levels as a foundation for rapid price growth.

Pesaing Fractyl Health, Inc.